English is not an official language of the Swiss Confederation. This translation is provided for information purposes only and has no legal force. Federal Act on the Transplantation of Organs, Tissues and Cells (Transplantation Act) of 8 October 2004 (Status as of 1 January 2014) Please note: this translation does not yet include the amendments of 01.05.2016 Please note: this translation does not yet include the amendments of 01.01.2017 The Federal Assembly of the Swiss Confederation, based on Article 119a paragraphs 1 and 2 of the Federal Constitution1, and having considered the Dispatch of the Federal Council of 12 September 20012, decrees: Chapter 1: General Provisions

It is prohibited to grant or derive financial gain or any other advantage from a donation of human organs, tissues or cells.

The following are not regarded as financial gain or other advantage:

1. reimbursement of loss of earnings and expenses incurred directly by the donor;

2. compensation for damage incurred by the donor as a result of organs, tissues or cells being removed;

3. a subsequent symbolic gesture of gratitude;

4. a crossover living donation.

It is prohibited:

1. to trade in human organs, tissues or cells in Switzerland or abroad (acting from Switzerland);

2. to remove or transplant human organs, tissues or cells which have been obtained in exchange for payment or by granting advantages.

This prohibition does not apply to:

1. the reimbursement of expenses incurred in the context of transplantation, and in particular costs for removal, transport, preparation, storage and transplantation;

2. transplant products in accordance with Article 49.

Organs, tissues or cells may be removed from a deceased person if:

1. the person has consented before his or her death to the removal;

2. death has been determined.

If no documented consent or refusal by the deceased person is available, the next of kin must be asked whether they are aware of the person having declared an intention to donate.

If the next of kin are not aware of any such declaration, organs, tissues or cells may be removed if the next of kin give consent. The decision of the next of kin shall be guided by what they believe the deceased person would have wanted.

If there are no next of kin, or they cannot be contacted, removal is not permitted.

The wishes of the deceased person take priority over those of the next of kin.

If the deceased person has demonstrably delegated the decision on the removal of organs, tissues or cells to a trusted person, this person shall be consulted instead of the next of kin.

Individuals who have reached the age of 16 may declare their intention to donate.

The next of kin shall be defined by the Federal Council.

A person is dead if the functions of his or her brain, including the brain stem, have ceased irreversibly.

The Federal Council shall issue regulations on the determination of death. In particular, it shall specify:

1. which clinical signs must be present so that it can be concluded that the functions of the brain, including the brain stem, have ceased irreversibly;

2. the requirements which must be fulfilled by the doctors who determine death.

Medical measures intended solely to preserve organs, tissues or cells may only be undertaken prior to the death of the donor if the donor has been informed comprehensively and has freely given his or her consent.

Such measures are prohibited if they:

1. hasten the death of the patient;

2. may lead to the donor entering a permanent vegetative state.

If a person has not declared his or her intention of donating, such measures may be carried out after the death of the patient until the next of kin have reached a decision. The Federal Council shall specify the maximum length of time during which such measures may be carried out.

Doctors who determine the death of a person may not:

1. participate either in the removal or the transplantation of organs, tissues or cells;

2. be subject to orders from a medical professional who is involved in such activities.

Doctors who remove or transplant organs, tissues or cells and associated medical personnel must not pressurise individuals who are caring for the dying person or who determine death or attempt to influence them in any other way.

Organs, tissues and cells may not be removed from persons who are incapable of judgement or who are minors.

Exceptions may be permitted for the removal of tissues or cells capable of regeneration if:

1. removal involves only a minimal risk and a minimal burden for the person who are incapable of judgement or minor;

2. the recipient cannot be treated with any other therapeutic method with comparable benefit;

3. no suitable adult donor who is capable of judgement is available;

4. the recipient is a parent, child or sibling of the donor;

5. the donation is likely to save the recipient's life;

6. the legal representative has been informed comprehensively and has freely given his or her consent in writing;

7. the donor who is a minor capable of judgement has been informed comprehensively and has freely given his or her consent in writing;

8. there is no indication that the person incapable of judgement would object to removal;

9. an independent authority has given permission.

A person incapable of judgement must be involved as far as possible in the information and consent process.

Expression in accordance with Annex No 21 para.¹ of the Federal Act of 18 Dec. 2008 (Adult Protection, Law of Persons and Law of Children), in force since 1 Jan. 2013 (AS 2011 725; BBl 2006 7001). This amendment has been made throughout the text.

Expression in accordance with Annex No 21 para.² of the Federal Act of 18 Dec. 2008 (Adult Protection, Law of Persons and Law of Children), in force since 1 Jan. 2013 (AS 2011 725; BBl 2006 7001). This amendment has been made throughout the text.

The cantons shall specify the independent authority in accordance with paragraph 2 letter i and shall regulate the process.

Any person who removes organs, tissues or cells from a living person must ensure that this person is adequately insured against possible serious consequences of removal.

The insurer who would be responsible for the costs of treating the recipient's illness if no living donation were available shall be responsible for:

1. the cost of this insurance;

2. appropriate compensation for loss of earnings or other expenses incurred by the donor in connection with removal.

The duty to bear costs stipulated in paragraph 2 shall also apply if the removal or transplantation cannot be carried out. If the recipient's insurer is not known, the Confederation shall bear the costs.

The Federal Council shall specify in particular:

1. the serious consequences against which the donor must be insured;

2. the content and scope of the insurance stipulated in paragraph 1;

3. any other expenses for which the donor shall be compensated in accordance with paragraph 2 letter b.

The Federal Council shall specify the requirements which information must fulfil under the terms of Articles¹² letter b and 13 paragraph 2 letters f and g.

It may specify which other therapeutic methods have no comparable benefit for the recipient.

This section concerns the allocation of organs which the donor has not donated for a specific person.

The Federal Council:

1. shall specify which organs shall be allocated in accordance with this section;

2. may also declare this section to be applicable to the allocation of tissues and cells.

No-one may be discriminated against with respect to the allocation of organs.

Persons resident in Switzerland must be treated equally with respect to allocation.

A person who is not resident in Switzerland and who has been included on the waiting list in accordance with Article 21 paragraph 1 will be allocated an available organ if:

1. the transplantation is medically urgent and there is no-one resident in Switzerland who is in a similar situation; or

2. the transplantation is not medically urgent and no recipient resident in Switzerland can be identified.

There is no fundamental right to allocation of an organ.

The following criteria in particular shall be observed when allocating organs:

1. the medical urgency of a transplantation;

2. the medical benefit of a transplantation;

3. the waiting time.

When allocating organs, an effort must be made to ensure that patients who, because of their physiological characteristics, are likely to have to wait a very long time have the same probability of being allocated an organ as patients without these characteristics.

The Federal Council shall specify the order in which the criteria are to be applied, or shall give them a weighting.

The Confederation shall create a national organ allocation office.

The national organ allocation office:

1. keeps a list of individuals waiting to receive an organ (waiting list);

2. allocates available organs to recipients after consultation with the transplant centres;

3. organises and coordinates at national level all activities relating to allocation;

4. collaborates with allocation organisations in other countries.

The national organ allocation office shall document each decision and retain this documentation for ten years.

The Federal Council shall regulate the allocation procedure.

Persons resident in Switzerland may be placed on the waiting list. The Federal Council shall determine which persons not resident in Switzerland may be placed on the waiting list.

The transplant centres shall decide whom to place on or remove from the waiting list. They may take only medical reasons into account. Article 17 paragraph 1 applies mutatis mutandis.

The transplant centres shall communicate their decisions with the necessary data to the national organ allocation office.

The Federal Council shall specify in more detail:

1. the medical reasons according to paragraph 2;

2. the necessary data according to paragraph 3.

Hospitals and transplant centres shall inform the national organ allocation office, sending the necessary data, of all deceased persons who meet the criteria for organ removal. The Federal Council shall specify in more detail the necessary data.

Doctors, hospitals and transplant centres to whom a person has declared while alive his or her willingness to donate an organ have a duty to register this person with the national organ allocation office.

If no recipient can be found for an organ in Switzerland, the national organ allocation office shall offer the organ to a foreign organ allocation organisation. The right to exchange an organ under an international patients' programme in accordance with

Offers or organs from other countries may only be accepted by the national organ allocation office.

The national organ allocation office may conclude agreements governing reciprocal organ exchange with foreign organ allocation offices. This shall require the approval of the Swiss Federal Office of Public Health (Federal Office).

Any person who removes organs, tissues or cells must notify the Federal Office of this.

The Federal Council shall specify the content of the notification and the duties of the notifier.

Authorisation from the Federal Office is required by any person who:

1. stores tissues or cells;

2. imports or exports organs which are not allocated in accordance with Articles 16–23, tissues or cells.

Storage in a bonded warehouse shall be considered as importation.

Authorisation shall be granted if:

1. the necessary technical and operative requirements have been fulfilled;

2. a suitable quality assurance system is in place.

The Federal Council shall regulate the preconditions for authorisation and the authorisation procedure and shall specify the duties of persons who require approval.

Organs may only be transplanted in transplant centres which have been granted the appropriate authorisation by the Federal Office.

Authorisation shall be granted if:

1. the necessary technical and operative requirements have been fulfilled;

2. a suitable quality assurance system is in place which also ensures that the health status of living donors is followed up;

3. the quality of the transplantations is ensured.

Transplant centres must record, evaluate and regularly publish the outcome of transplantations using standardised criteria.

The Federal Council may make the transplantation of tissues or cells contingent on approval from the Federal Office.

Any person who transplants tissues or cells must notify the Federal Office of this.

The Federal Council shall specify the content of the notification and the duties of the notifier.

Any person who removes or transplants organs, tissues or cells must verify the suitability of donors.

The following must be excluded as donors:

1. any person who has received a transplant of organs, tissues or cells of animal origin or transplant products obtained therefrom;

2. any person other than those mentioned under letter a whose organs, tissues or cells could transmit pathogenic agents or otherwise harm the health of the recipient; Article 31 paragraph 2 letter c applies notwithstanding.

The Federal Council shall regulate the requirements regarding donor suitability, responsibility for verifying suitability and the data that shall be recorded in the process.

Any person who removes or transplants organs, tissues or cells must make certain that these have been tested for pathogenic agents or markers thereof.

The Federal Council shall specify in particular:

1. which tests for pathogenic agents or markers thereof must be carried out;

2. which tests may be used;

3. the cases in which organs, tissues or cells may be transplanted in spite of the test results being reactive.

It may provide for exemptions from mandatory testing if it can be ensured by other means that infection with pathogenic agents is excluded.

Any person who handles organs, tissues or cells must:

1. record all procedures and transactions of significance for the protection of health;

2. keep these records in such a way that the data can be traced back as far as the donor and the recipient.

In particular, for each instance of removal or transplantation of organs, tissues or cells, the surname, first name and date of birth of both donor and recipient must be recorded.

The records specified in Article 34 and all important documents shall be kept for

years.

If the business activity ends before this period expires, the complete documentation shall be stored safely or, if this is not possible, handed over to the Federal Office.

Clinical trials involving the transplantation of human organs, tissues or cells require authorisation from the Federal Office in advance. For certain trials, the Federal Council may grant an exemption from mandatory authorisation or specify mandatory notification.

The Federal Office shall determine whether the organs, tissues or cells used in a clinical trial meet the requirements specified in this Act. It may inspect clinical trials at any time.

The Federal Council shall issue regulations concerning the procedure. It may specify mandatory authorisation for changes to clinical trials.

Amended by Annex No 4 of the Human Research Act of 30 Sept. 2011, in force since 1 Jan. 2014 (AS 2013 3215; BBl 2009 8045).

It may specify notification or information requirements, in particular with regard to:

1. the completion or discontinuation of a clinical trial;

2. adverse events observed in connection with a clinical trial;

3. the occurrence of circumstances during the conduct of a clinical trial which could affect the safety or health of the participants.

In issuing regulations in accordance with paragraphs 3 and 4, the Federal Council shall have regard to recognised international regulations.

For clinical trials, the Human Research Act of 30 September 2011⁶ is also applicable.

The time and method of a termination of pregnancy must be selected independently of subsequent transplantation of embryonic or foetal human tissues or cells.

It is prohibited:

1. to keep superfluous embryos alive artificially after the seventh day of development or to keep aborted embryos or intact foetuses alive artificially for the purpose of remove tissues or cells from them for transplantation;

2. to transplant embryonic or foetal tissues or cells into a person designated for this purpose by the donor;

3. to use embryonic or foetal tissues or cells from women who are incapable of judgement for transplantation purposes.

Any person who wishes to transplant embryonic or foetal human tissues or cells into humans shall require authorisation by the Federal Office.

Authorisation shall be granted for a clinical trial if:

1. a therapeutic benefit can be expected;

2. the necessary technical and operative requirements have been fulfilled;

3. a suitable quality assurance system is in place.

Authorisation shall be granted for standard treatment if:

4. a therapeutic benefit has been demonstrated;

5. the recipient cannot be treated with another therapeutic method with comparable benefit;

A woman may not be asked to donate embryonic or foetal human tissues or cells for transplantation purposes before she has taken the decision to terminate the pregnancy.

Embryonic or foetal human tissues or cells may only be transplanted if the donor has been informed comprehensively and has consented freely and in writing to the intended use.

A couple may not be asked to donate tissues or cells from a superfluous embryo for transplantation purposes until it has been established that the embryo is superfluous.

Tissues or cells from superfluous embryos may only be transplanted if the affected couple has been informed comprehensively and has consented freely and in writing to the intended use.

Any person who wishes to transplant organs, tissues or cells of animal origin or transplant products obtained therefrom into humans shall require authorisation from the Federal Office.

Authorisation shall be granted for a clinical trial if:

1. a risk of infection for the population can be excluded with a high degree of probability;

2. a therapeutic benefit can be expected;

3. the necessary technical and operative requirements have been fulfilled;

4. a suitable quality assurance system is in place.

Authorisation shall be granted for standard treatment if:

1. a risk of infection for the population can be excluded;

2. a therapeutic benefit has been demonstrated;

3. the requirements stipulated in paragraph 2 letters c and d have been fulfilled.

The Federal Council shall issue regulations concerning the handling of organs, tissues and cells of animal origin. In particular, it shall specify:

1. requirements concerning the handling of donor animals;

2. requirements concerning the quality of the animal organs, tissues or cells;

3. the requirements concerning tests to monitor the health of recipients and donor animals;

4. the preconditions for authorisation and the authorisation procedure;

5. the duration and nature of retention of recorded data and transactions and biological samples that have been taken;

6. the pathogenic agents or markers for which tests must be carried out;

7. the circumstances in which organs, tissues and cells of animal origin for which the test results are reactive may be transplanted;

8. the labelling of organs, tissues or cells of animal origin which have been obtained from genetically modified animals;

9. the requirements concerning: 1. information of and consent by the recipient, 2. information of medical personnel and their consent to measures affecting them, and 3. information of the recipient's close contacts.

The Federal Council may:

1. restrict or prohibit the use of certain species of animals for transplantation purposes;

2. grant exemptions from mandatory testing according to Article 45 if it can be ensured by other means that infection with pathogenic agents can be excluded;

3. specify other duties of the holder of the authorisation and duties of the recipient if required by changing circumstances;

4. declare Articles 6–42 to be applicable to the handling of organs, tissues or cells of animal origin.

In addition to the provisions of this Act, Articles 3, 5–33, 58–67 and 84–90 TPA⁷ apply mutatis mutandis to the handling of transplant products.

The Swiss Agency for Therapeutic Products shall also be responsible for inspections according to Article 60 paragraph 2 TPA with respect to transplant products.

In addition, Articles 36-41 and 53-57 TPA also apply mutatis mutandis to the handling of transplant products obtained from human organs, tissues and cells.

Any person who removes organs, tissues or cells for the manufacture of transplant products must verify the suitability of the donor as stipulated in Article 36 TPA.

Article 86 paragraph 1d TPA also applies to the handling of human transplant products.

The Confederation shall enforce this Act unless it declares this to be the responsibility of the cantons.

The Federal Council shall issue the implementing regulations.

The Confederation shall monitor the enforcement of this Act by the cantons.

It shall coordinate their enforcement activities if it has an interest in enforcement being standardised throughout Switzerland. To this end it may, in particular:

1. oblige the cantons to inform it about their enforcement activities;

2. prescribe activities for the cantons to ensure standardised enforcement.

The Federal Council may delegate enforcement duties to organisations and persons under public or private law.

This applies in particular to:

1. the allocation of organs in accordance with Article 19;

2. the keeping of a stem cell register in accordance with Article 62;

3. monitoring in accordance with Article 63.

The Federal Council shall ensure that the delegated duties are remunerated.

The Federal Office shall ensure that the enforcement and impact of this Act are evaluated scientifically.

These evaluations shall focus on:

1. the influence of the Act on the situation, attitude and behaviour of the population and medical personnel;

2. the practice of allocating organs, the quality of transplantations, and the availability of organs, tissues and cells for transplantation.

The Federal Department of Home Affairs shall report the results of completed evaluations to the Federal Council and shall make a recommendation on the next course of action to the Federal Council.

The cantons shall organise and coordinate activities relating to transplantation in:

1. hospitals that care for donors;

2. transplant centres.

In particular, they shall ensure that at each of these hospitals and at the transplant centres:

1. one person is responsible for local coordination;

2. the necessary continuing and in-service training programmes for the medical staff are provided.

The person responsible for local coordination shall ensure in particular that:

1. donors and their families receive appropriate care;

2. donors are reported to the national organ allocation office (Art. 22).

Where no overriding and conflicting private interest exists, data may, in individual cases and following a written, justified request, be provided to:

1. civil courts if the data is required to judge a court case;

2. criminal courts and criminal investigation authorities if the data is required to investigate a felony or misdemeanour.

Where no overriding and conflicting private interest exists, data may be provided to:

1. the offices within the Confederation and cantons responsible for enforcing this Act and organisations or persons under public or private law if they require the data to fulfil the duties assigned to them under this Act;

2. criminal investigation authorities if required to prosecute or prevent a felony or an offence under this Act.

Data which is of general interest and relates to the application of this Act may be published. The individuals concerned must not be identifiable.

In other cases, data may be provided to third parties as follows:

1. data not relating to specific persons, provided that there is an overriding interest in this data being made available;

2. personal data, provided that the individual concerned has given written consent in each case.

Only data necessary for the intended purpose may be provided.

The Federal Council shall regulate the details of the provision of data and the information that shall be given to the individuals concerned.

The Federal Council shall regulate responsibilities and the procedures for exchanging data with foreign authorities and institutions and with international organisations.

Confidential data may only be provided to foreign authorities and institutions or to international organisations if:

1. required by agreements under international law or resolutions passed by international organisations;

2. necessary to avert an imminent danger to life or health; or

3. this would enable illegal trade or other serious offences under this Act to be exposed.

The Federal Office and the cantons shall regularly inform the public about matters concerning transplantation medicine. To this end they may collaborate with organisations and persons under public or private law.

This information shall cover:

1. explanation of the ways in which an individual can express his or her wishes concerning the donation of organs, tissues or cells and the consequences of expressing such wishes;

2. the legal situation and practical aspects, i.e. explanation of the preconditions for the removal, allocation and transplantation of organs, tissues and cells in Switzerland.

The Federal Council may determine that a declaration of volition to donate organs, tissues or cells may be recorded on a suitable document or information storage medium.

The Federal Office shall keep a stem cell register.

The purpose of the stem cell register is to find suitable stem cells for a specific recipient. The data recorded in this register may only be used for this purpose.

The data stored in the stem cell register are those necessary to determine the tissue match of:

Any person who processes data of the type referred to in paragraph 3 must report them to the register. These data should only be reported in conjunction with a person's name if required by the purpose of the register.

A person entered in the register may request the deletion of data referring to him or her at any time.

The Federal Council shall specify the types of stem cells for which a register will be kept.

The Federal Office shall monitor compliance with the provisions of this Act. In particular it shall carry out periodic inspections to this end.

It may, free of charge, take the necessary samples, request the necessary information or documents and request any other assistance required. It may instruct the customs authorities to obtain samples.

It may enter sites, establishments and premises and search vehicles in pursuit of its duties.

The Federal Office may take any measures necessary to enforce this Act.

In particular it may:

1. issue notices of non-compliance and set an appropriate deadline for rectification of the situation;

2. seize and destroy organs, tissues and cells or transplant products that endanger health or do not comply with the requirements of this Act;

3. forbid the use of premises or establishments or close plants;

4. suspend or revoke authorisations or approvals.

The Federal Office may take necessary precautionary measures. In particular it may seize or hold organs, tissues or cells or transplant products which are deemed to be non-compliant or in the event of a reasonable suspicion.

Where an infringement of the terms of this Act is suspected, the customs authorities shall be entitled to retain shipments containing organs, tissues, cells or transplant products at the border or in bonded warehouses and to involve the Federal Office. The Federal Office shall carry out subsequent investigations and instigate the necessary measures.

Fees shall be levied in respect of:

1. the granting, suspension or revocation of authorisations;

2. the conduct of inspections;

3. the ordering and performance of measures.

The Federal Council shall set the fees for enforcement by the federal authorities.

Appeals may be filed with the Federal Administrative Court with respect to rulings derived from this Act and its implementing ordinances.

If an appeal against a ruling on the allocation of organs is justified, the Federal Administrative Court shall only determine the degree to which federal law has been infringed by the contested ruling.

The right of appeal shall otherwise be governed by the general provisions on the Administration of Federal Justice.

Amended by No I¹¹ of the Ordinance of the Federal Assembly of 20 December 2006 on the Amendment of Legislation in accordance with the Provisions of the Federal Supreme Court Act and the Administrative Court Act, in force since 1 July 2007 (AS 2006 5599; BBl 2006 7759).

Provided that no more serious offence has been committed under the Criminal Code¹⁰, a term of imprisonment or a fine of up to 200,000 francs shall be imposed on anyone who wilfully:

1. grants or accepts a financial gain or other advantage for the donation of human organs, tissues or cells (Art.⁶ para. 1);

2. places human organs, tissues or cells on the market in Switzerland or abroad (acting from Switzerland) in exchange for payment, or removes or transplants human organs, tissues or cells which have been obtained in exchange for payment or advantages (Art.⁷ para. 1);

3. removes organs, tissues or cells from a deceased person without consent having been given (Art. 8);

4. infringes the regulations governing preparatory medical measures (Article 10);

5. removes organs, tissues or cells and in so doing creates a serious risk for the life or health of the donor (Art.¹² let. c);

6. removes organs, tissues or cells from living persons who are incapable of judgement or who are minors without the preconditions for this having been met (Art. 13 para.² and 3);

7. discriminates against persons with respect to inclusion in the waiting list or the allocation of organs (Art. 17 and 21 para. 2) or fails to allocate organs in accordance with the decisive criteria (Art. 18);

8. infringes the regulations concerning the special duty of care (Art. 30–35 and 45) in so doing puts the health of people at risk;

9. carries out clinical trials which do not comply with the requirements of this Act and in so doing endangers the health of people (Art. 36);

10. determines the time and method of the termination of a pregnancy to coincide with the transplantation of embryonic or foetal human tissues or cells (Art. 37 para. 1);

11. obtains superfluous embryos after the seventh day of their development or keeps aborted embryos or intact foetuses alive artificially in order to remove tissues or cells from them for transplantation purposes (Article 37 para.² let.

1. a) ;

12. transplants embryonic or foetal tissues or cells into a person who has been designated for this purpose by the donor (Art. 37 para.² let. b);

As of 1 January 2007 penalties and prescriptive periods shall be interpreted and/or amended in application of Art. 333 para. 2-6 of the Criminal Code (SR 311.0) in accordance with the Federal Act of 13 December 2002 (AS 2006 3459).

13. uses embryonic or foetal tissues or cells from women who are incapable of judgement for the purpose of transplantation (Art. 37 para.² let. c);

14. infringes the regulations governing the information and consent of the donor or the couple concerned (Art. 39 and 40).

If the act is committed for commercial gain, the penalty shall be up to five years'

If the act is committed through negligence, the penalty shall be up to six months'

A term of detention or a fine of up to CHF 50,000 shall be imposed on anyone who, without having committed a misdemeanour under Art. 69, wilfully or neglia. infringes the regulations governing the removal of organs, tissues or cells for purposes other than transplantation (Art. 5);

2. infringes the regulations concerning the independence of the persons concerned (Art.¹¹ and 41);

3. removes organs, tissues or cells from a living person even though the recipient could have been treated with a different therapeutic method with comparable benefit (Art.¹² let. d);

4. infringes a duty of notification (Art. 20, 21 para. 3, 22, 24, 29, 36 and 62 para. 4);

5. accepts without authorisation organs offered from another country (Art. 23 para. 2);

6. performs without authorisation acts which require authorisation or fails to fulfil conditions attached to such authorisation (Art. 25, 27, 38 and 43);

7. breaches the duty of confidentiality, provided that neither Article 320 nor

Attempts and aiding and abetting are also offences.

The right to prosecute the foregoing contraventions and execute the penalties therefor are subject to a five-year prescriptive period.

In particularly minor cases, the requirement to report, prosecute or penalise the offence may be waived.

The cantons have jurisdiction for the prosecution and judgement of offences.

Articles⁶, ⁷ (offences committed within a business) and 15 (forgery of documents, obtaining a false certificate by fraud) of the Federal Act of 22 March 1974¹² on Administrative Criminal Law apply.

Anyone who has already begun an activity within the meaning of Articles 24 and

must notify this to the Federal Office within six months of the commencement of this Act.

Anyone who has already begun an activity within the meaning of Articles 25 and

must submit an application for authorisation to the Federal Office within six months of the commencement of this Act. He or she may continue to pursue the activity until the Federal Office reaches a decision.

Authorisations granted in accordance with Articles 18 and 18a of the Federal Decree of 22 March 199615 on the Control of Transplants shall remain valid until the period of authorisation expires.

The Federal Office reserves the right to instigate measures in accordance with

This Act is subject to an optional referendum.

The Federal Council shall determine the date on which this Act comes into force.

AS 1996 2296, 2001 1505 2790 Annex No⁷, 2002 3335 Art. 1, 2005 4779

The amendments may be consulted under AS 2007 1935.

AS 1996 2296, 2001 1505 Commencement date: 1 July 200716

Federal Council Decree of 16 March 2007 (AS 2007 1960)